7121 Bevacizumab (BEV) and interferon (IFN) therapy does not increase risk of cardiac events in metastatic renal cell carcinoma (mRCC)
暂无分享,去创建一个
A. Ravaud | B. Melichar | J. Bellmunt | S. Bracarda | B. Escudier | S. Négrier | R. Laeufle | V. Sneller